Kids need the COVID-19 jab for herd immunity
James Cook University scientists have developed a new model to track the COVID pandemic—and it's telling them Australia should now prioritize delivering the Pfizer vaccine to 12-40 year-olds.
Epidemiologist Professor Emma McBryde and mathematician Dr. Michael Meehan from JCU's Australian Institute of Tropical Health and Medicine produced the model, demonstrated in a new paper in the Medical Journal of Australia today.
Professor McBryde said the new model incorporates age-specific mixing, infectiousness, susceptibility and severity to assess the impact of the epidemic under different public health intervention scenarios.
"We have developed a simple, flexible online tool that is now being used around the world to develop vaccine implementation strategies. We've made it fully open-source to allow for the greatest transparency and examination of our methods," said Professor McBryde.
She said the scientists investigated two alternative strategies for vaccine distribution: the first focused on vaccinating the vulnerable (people 55 and over) and the second prioritizes vaccinating the most infectious (those under 55).
"We also produced results for AstraZeneca only, Pfizer only, and the current mixed program of vaccinating under 60 year-olds with Pfizer and 60 year-olds and older with AstraZeneca," said Professor McBryde.
She said the modeling showed the current strategy of vaccinating the vulnerable older age groups first is the optimal strategy for reducing hospitalisations, deaths and years of life lost.
But she said there were uncertainties in the forecast, the most important hinging on the difficulty of establishing the effective reproduction number of the Delta Strain (the number of people one infectious person passes the virus on to).
"Estimates range from 3 to 7. At the midrange of most estimates, a reproduction number of 5, at least 85 percent of the population -including children- would need to be vaccinated to achieve herd immunity."
She said if the reproduction number is 3, the current program can achieve herd immunity at 60-70 percent coverage without vaccinating 5-15 year-olds. But on the other side of the ledger, an effective reproduction number of 7 means achieving herd immunity with existing vaccines would be impossible.
"We are unlikely to achieve herd immunity at the most plausible reproduction number of 5 unless vaccination is extended to younger ages or combined with other measures. Australia should now prioritize delivering Pfizer vaccine to 12-40 year-olds," said Professor McBryde.
She said the good news was that vaccination under any scenario was a vastly preferrable option.
"Vaccination still prevents over 85% of deaths compared with no vaccination and even current vaccine targets are expected to prevent substantial numbers of deaths," said Professor McBryde.